Steris STE
NYSE STE
$235.76 -1.15 (-0.49%)
As of: Aug 20, 2026 · 3:59 PM EDT

Steris (STE) Long-Term Debt Issuances (2021)

Steris (STE) posted quarterly Long-Term Debt Issuances of -$700.0 million for Q3 2021, down 151.85% quarter-over-quarter from $1.4 billion in Q2 2021.

Steris (STE) Long-Term Debt Issuances (2021) Analysis & Trends

Steris' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at -$700.0 million for Q3 2021.

  • In Q3 2021, Long-Term Debt Issuances changed N/A year-over-year to -$700.0 million; the TTM figure through Jun 2022 stood at -$700.0 million (down 136.84% YoY), while the FY2022 annual figure was $650.0 million, up 18.18% from the prior year.
  • Long-Term Debt Issuances for Q3 2021 stood at -$700.0 million, down from $1.4 billion in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $1.4 billion in Q2 2021, with the low at -$700.0 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -33.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 109.26 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 19.04 Bn 18.63 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2021 -700.00 Mn
Sep 30, 2021 -700.00 Mn
Jun 30, 2021 1.35 Bn
Jun 30, 2021 1.35 Bn
Mar 31, 2021 550.00 Mn
Mar 31, 2021 550.00 Mn